Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Serum 25-hydroxyvitamin D and serum phosphate levels increased (P < .001), whereas alkaline phosphatase decreased postoperatively.
Source: Normalization of Biochemical Parameters 3 Months After Parathyroidectomy. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Observational study.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A prospective observational study was conducted in the spring and fall of 2023.
Source: Abstract.
Only postmenopausal women were included, to control for sex hormone differences.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Parathyroidectomy Restores Muscle Strength and Transcriptome in Individuals With Primary Hyperparathyroidism
Observational study · The Journal of Clinical Endocrinology and Metabolism · 2026
Original publication title
Parathyroidectomy Restores Muscle Strength and Transcriptome in Individuals With Primary Hyperparathyroidism
© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Determining functional and molecular changes in skeletal muscle before and after parathyroidectomy.
Source: ObjectiveAbstract: What methods does the paper describe?
A prospective observational study was conducted in the spring and fall of 2023. Patients underwent surgery at the Endocrine and Sarcoma unit at the Karolinska University Hospital in Stockholm, Sweden. A total of 21 postmenopausal women with primary hyperparathyroidism planned for surgery were included, whereof 15 completed the study protocol. Participants had no disabling comorbidities. Muscle function tests, muscle biopsies, MRI, and biochemical panels were analyzed before and after parathyroidectomy. Muscle composition of m. vastus lateralis was tested with MRI and transcriptomic analysis of muscle biopsies.
Leg strength was evaluated with timed stands test and peak torque tests. Activity level was estimated from questionnaires.
Source: MethodsAbstract: Context
Primary hyperparathyroidism leads to hypercalcemia and muscle dysfunction. Muscle weakness is associated with increased morbidity and mortality but is overlooked in surgical treatment guidelines. While parathyroidectomy is the only curative treatment, its effects on skeletal muscle strength and molecular remodeling remain underexplored.
Source: ContextAbstract: Results
Parathyroidectomy normalized calcium levels (P < .001) and improved muscle strength (P < .005). Muscle volume increased (P = .023) and fat fraction was reduced (P = .013), without changes in physical activity levels. Transcriptomic analysis identified 981 differentially expressed genes postsurgery, enriched in pathways mirroring exercise-induced adaptations.
Source: ResultsAbstract: Conclusion
These findings highlight the impact of parathyroidectomy on skeletal muscle function and suggest that muscle assessments should be included in surgical referral criteria to address age-related muscle decline and improve long-term outcomes.
Source: ConclusionAuthors’ abstract
Abstract
Context
Primary hyperparathyroidism leads to hypercalcemia and muscle dysfunction. Muscle weakness is associated with increased morbidity and mortality but is overlooked in surgical treatment guidelines. While parathyroidectomy is the only curative treatment, its effects on skeletal muscle strength and molecular remodeling remain underexplored.
Objective
Determining functional and molecular changes in skeletal muscle before and after parathyroidectomy.
Methods
A prospective observational study was conducted in the spring and fall of 2023. Patients underwent surgery at the Endocrine and Sarcoma unit at the Karolinska University Hospital in Stockholm, Sweden. A total of 21 postmenopausal women with primary hyperparathyroidism planned for surgery were included, whereof 15 completed the study protocol. Participants had no disabling comorbidities. Muscle function tests, muscle biopsies, MRI, and biochemical panels were analyzed before and after parathyroidectomy. Muscle composition of m. vastus lateralis was tested with MRI and transcriptomic analysis of muscle biopsies.
Leg strength was evaluated with timed stands test and peak torque tests. Activity level was estimated from questionnaires.
Results
Parathyroidectomy normalized calcium levels (P < .001) and improved muscle strength (P < .005). Muscle volume increased (P = .023) and fat fraction was reduced (P = .013), without changes in physical activity levels. Transcriptomic analysis identified 981 differentially expressed genes postsurgery, enriched in pathways mirroring exercise-induced adaptations.
Conclusion
These findings highlight the impact of parathyroidectomy on skeletal muscle function and suggest that muscle assessments should be included in surgical referral criteria to address age-related muscle decline and improve long-term outcomes.
Publication and source details
Original title: Parathyroidectomy Restores Muscle Strength and Transcriptome in Individuals With Primary Hyperparathyroidism
Sofia Björnsdotter-Öberg; Anna Koman; Mikael Skorpil; Henric Rydén; Johanna T Lanner; Anna Krook; Inga-Lena Nilsson; Nicolas J Pillon; Carolina Nylén
The Journal of Clinical Endocrinology and Metabolism · 2026
Correspondence: Carolina Nylén, PhD, MD, Department of Molecular Medicine and Surgery, Karolinska University Hospital, Solna L1 :00, Stockholm 171 76, Sweden. Email: carolina.nylen@ki.se.© The Author(s) 2025. Published by Oxford University Press on behalf of the Endocrine Society.2025https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms. Swedish Society of Medicine10.13039/501100007687 SLS-986646 Lisa: and Johan Grönberg foundation10.13039/501100008310 2024-010 Swedish Research Council10.13039/501100004359 2022-006092022-01650 Novo Nordisk Foundation10.13039/501100009708 NNF24OC0088739 European Foundation for the Study of Diabetes10.13039/501100001648 NNF/EFSD NNF21SA0072747 Diabetes Wellness Network Sverige PG21-6524Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:52:49.676512+00:00
DOI: 10.1210/clinem/dgaf418 · PMC12819853